John Betteridge

John Betteridge

UNVERIFIED PROFILE

Are you John Betteridge?   Register this Author

Register author
John Betteridge

John Betteridge

Publications by authors named "John Betteridge"

Are you John Betteridge?   Register this Author

87Publications

2214Reads

46Profile Views

Levels of Vitamin D are Low After Crohn's Disease is Established But Not Before.

Clin Gastroenterol Hepatol 2019 Oct 4. Epub 2019 Oct 4.

Harvey M. and Lyn P. Meyerhoff Inflammatory Bowel Disease Center, Division of Gastroenterology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland; Division of Gastroenterology and Hepatology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, and Department of Genetics and the Human Genetics Institute of New Jersey, Rutgers University, New Brunswick, New Jersey. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2019.09.034DOI Listing
October 2019

Diabetogenic Action of Statins: Mechanisms.

Curr Atheroscler Rep 2019 Apr 30;21(6):23. Epub 2019 Apr 30.

Endocrinology and Metabolism, University College, London, UK.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11883-019-0780-z
Publisher Site
http://dx.doi.org/10.1007/s11883-019-0780-zDOI Listing
April 2019

Extraintestinal Manifestations Are Common in Obese Patients with Crohn's Disease.

Inflamm Bowel Dis 2017 09;23(9):1637-1642

*Gastroenterology Service, Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland; †Uniformed Services University of Health Sciences, Bethesda, Maryland; and ‡Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001187DOI Listing
September 2017

IBD HINTS for Preventive Care.

Inflamm Bowel Dis 2017 09;23(9):E42

*Gastroenterology Service, Department of Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland †Lancaster Gastroenterology Inc, Lancaster, Pennsylvania ‡Uniformed Services University of Health Sciences, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000001177DOI Listing
September 2017

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

J Med Genet 2016 12 1;53(12):835-845. Epub 2016 Sep 1.

Department of Atherosclerosis Research, Children's Hospital Oakland Research Institute, Oakland, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2016-103966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309131PMC
December 2016

Effect of atorvastatin on glycaemia progression in patients with diabetes: an analysis from the Collaborative Atorvastatin in Diabetes Trial (CARDS).

Diabetologia 2016 Feb 17;59(2):299-306. Epub 2015 Nov 17.

Diabetes Epidemiology Unit, Division of Population Health Sciences, University of Dundee, The Mackenzie Building, Kirsty Semple Way, Dundee, DD2 4BF, Scotland, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00125-015-3802-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705133PMC
February 2016

The diabetogenic action of statins - mechanisms and clinical implications.

Nat Rev Endocrinol 2016 Feb 15;12(2):99-110. Epub 2015 Dec 15.

Department of Medicine, University of Valencia, Avenida Blasco Ibañez, 17, 46010 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2015.194DOI Listing
February 2016

Drug-induced liver injury from initial dose of infliximab.

Mil Med 2015 Jun;180(6):e723-4

Department of Gastroenterology, Walter Reed National Military Medical Center, 8901 Wisconsin Avenue, Bethesda, MD 20889.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7205/MILMED-D-14-00485DOI Listing
June 2015

Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.

Am J Cardiol 2015 Feb 29;115(4):447-53. Epub 2014 Nov 29.

Division of Cardiology, San Francisco General Hospital, San Francisco, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2014.11.026DOI Listing
February 2015

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.

Authors:
Iris Postmus Stella Trompet Harshal A Deshmukh Michael R Barnes Xiaohui Li Helen R Warren Daniel I Chasman Kaixin Zhou Benoit J Arsenault Louise A Donnelly Kerri L Wiggins Christy L Avery Paula Griffin QiPing Feng Kent D Taylor Guo Li Daniel S Evans Albert V Smith Catherine E de Keyser Andrew D Johnson Anton J M de Craen David J Stott Brendan M Buckley Ian Ford Rudi G J Westendorp P Eline Slagboom Naveed Sattar Patricia B Munroe Peter Sever Neil Poulter Alice Stanton Denis C Shields Eoin O'Brien Sue Shaw-Hawkins Y-D Ida Chen Deborah A Nickerson Joshua D Smith Marie Pierre Dubé S Matthijs Boekholdt G Kees Hovingh John J P Kastelein Paul M McKeigue John Betteridge Andrew Neil Paul N Durrington Alex Doney Fiona Carr Andrew Morris Mark I McCarthy Leif Groop Emma Ahlqvist Joshua C Bis Kenneth Rice Nicholas L Smith Thomas Lumley Eric A Whitsel Til Stürmer Eric Boerwinkle Julius S Ngwa Christopher J O'Donnell Ramachandran S Vasan Wei-Qi Wei Russell A Wilke Ching-Ti Liu Fangui Sun Xiuqing Guo Susan R Heckbert Wendy Post Nona Sotoodehnia Alice M Arnold Jeanette M Stafford Jingzhong Ding David M Herrington Stephen B Kritchevsky Gudny Eiriksdottir Leonore J Launer Tamara B Harris Audrey Y Chu Franco Giulianini Jean G MacFadyen Bryan J Barratt Fredrik Nyberg Bruno H Stricker André G Uitterlinden Albert Hofman Fernando Rivadeneira Valur Emilsson Oscar H Franco Paul M Ridker Vilmundur Gudnason Yongmei Liu Joshua C Denny Christie M Ballantyne Jerome I Rotter L Adrienne Cupples Bruce M Psaty Colin N A Palmer Jean-Claude Tardif Helen M Colhoun Graham Hitman Ronald M Krauss J Wouter Jukema Mark J Caulfield

Nat Commun 2014 Oct 28;5:5068. Epub 2014 Oct 28.

1] NIHR Barts Cardiovascular Biomedical Research Unit, Queen Mary University of London, London EC1M 6BQ, UK [2] Department of Clinical Pharmacology, William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London EC1M6BQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms6068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220464PMC
October 2014

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Circulation 2013 Oct 21;128(14):1504-12. Epub 2013 Aug 21.

Departments of Cardiology (S.M.B.) and Vascular Medicine (B.J.A., G.K.H., J.J.P.K.), Academic Medical Center, Amsterdam, The Netherlands; Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Boston, MA (S.M., P.M.R.); Center of Preventive Medicine, Oslo University Hospital, Ulleval and University of Oslo, Norway (T.R.P.); State University of New York Health Science Center, Brooklyn, NY (J.C.L.); Rosalind Franklin University of Medicine and Science, North Chicago, IL (K.M.A.W.); Department of Neurology and Stroke Center, Bichat University Hospital, Paris, France (P.A.); Global Pharmaceuticals Pfizer, New York, NY (D.A.D.); Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia (A.M.T.); Department of Biochemistry and Lipid Clinic, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia (D.R.S.); NHMRC Clinical Trials Centre, University of Sydney, Sydney, Australia (A.K.); Medical Research Institute, University of Dundee, Dundee, United Kingdom (H.M.C.); Centre for Diabetes, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom (G.A.H.); Department of Medicine, Royal Free and University College Medical School, London, United Kingdom (D.J.B.); School of Biomedicine, University of Manchester, Manchester, United Kingdom (P.N.D.); Touro University, Mare Island, CA (M.B.C.); Department of Medicine, University of Texas Health Science Center, and VERDICT, South Texas Veterans Health Care System, San Antonio, TX (J.R.D.); and Weill Cornell Medical College, New York, NY (A.M.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002670DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3807966PMC
October 2013

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).

Eur Heart J 2013 Oct 30;34(39):3035-87. Epub 2013 Aug 30.

The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines.

View Article

Download full-text PDF

Source
https://academic.oup.com/eurheartj/article-lookup/doi/10.109
Publisher Site
http://dx.doi.org/10.1093/eurheartj/eht108DOI Listing
October 2013

Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population.

Inflamm Bowel Dis 2013 Jun;19(7):1421-7

Gastroenterology Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland 20889, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/ibdjournal/2013/06010/Inflammat
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/MIB.0b013e318281334dDOI Listing
June 2013

Pulmonary carcinoid tumor in a patient on adalimumab for Crohn's disease.

Inflamm Bowel Dis 2013 Feb;19(2):E29-30

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.22913DOI Listing
February 2013

Cardiovascular endocrinology in 2012: PCSK9-an exciting target for reducing LDL-cholesterol levels.

Nat Rev Endocrinol 2013 Feb 8;9(2):76-8. Epub 2013 Jan 8.

Department of Diabetes and Endocrinology, University College Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrendo.2012.254DOI Listing
February 2013

Probiotics for the treatment of inflammatory bowel disease.

Curr Gastroenterol Rep 2012 Aug;14(4):324-33

Gastroenterology Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD 20889-0001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11894-012-0265-5DOI Listing
August 2012

'A lipaemic mystery': a patient with hypertriglyceridaemic pancreatitis and cerebral infarction.

BMJ Case Rep 2011 Dec 20;2011. Epub 2011 Dec 20.

Department of Medicine, University College London Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr.09.2011.4819DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246153PMC
December 2011

Lipid control in patients with diabetes mellitus.

Nat Rev Cardiol 2011 May 15;8(5):278-90. Epub 2011 Mar 15.

Department of Diabetes and Endocrinology, University College Hospital, 3rd Floor Central, 250 Euston Road, London NW1 2PQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrcardio.2011.23DOI Listing
May 2011

Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.

Diab Vasc Dis Res 2011 Apr;8(2):160-72

Duke Lipid Clinic, Department of Medicine, Box 3510, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164111406457DOI Listing
April 2011

Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.

Clin Sci (Lond) 2011 Jan;120(2):81-9

Department of Medicine, University of Hong Kong, Hong Kong, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20100256DOI Listing
January 2011

Pitavastatin - results from phase III & IV.

Authors:
John Betteridge

Atheroscler Suppl 2010 Dec;11(3):8-14

Consultant Physician and Emeritus Professor of Endocrinology and Metabolism, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1567-5688(10)71064-3DOI Listing
December 2010

CHICAGO, PERISCOPE and PROactive: CV risk modification in diabetes with pioglitazone.

Fundam Clin Pharmacol 2009 Dec 10;23(6):675-9. Epub 2009 Sep 10.

Department of Diabetes and Endocrinology, University College Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1472-8206.2009.00741.xDOI Listing
December 2009

Is the current therapeutic armamentarium in diabetes enough to control the epidemic and its consequences? What are the current shortcomings?

Acta Diabetol 2009 Sep 20;46(3):173-81. Epub 2009 Jun 20.

Division of Metabolic Diseases, Center of Excellence for Cardiovascular Diseases, Second University of Naples, Piazza Miraglia, 80138, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00592-009-0134-3DOI Listing
September 2009

Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14).

Am J Cardiol 2009 Jul 3;104(2):234-9. Epub 2009 Jun 3.

Takeda Pharmaceuticals North America, Inc., Deerfield, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2009.03.023DOI Listing
July 2009

Lipid lowering in diabetes mellitus.

Curr Opin Lipidol 2008 Dec;19(6):579-84

Department of Medicine, Royal Free and University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOL.0b013e328314b6b4DOI Listing
December 2008

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.

Eur Heart J 2008 Nov 7;29(21):2625-33. Epub 2008 Oct 7.

NIHR School of Primary Care Research, Division Public Health and Primary Health Care, University of Oxford, Old Road Headington, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehn422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2577142PMC
November 2008

The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).

Diab Vasc Dis Res 2008 Sep;5(3):177-83

Department of Medicine, New York University School of Medicine, VA Hospital, 423 East 23rd Street, Dept of Medicine -11093 South, New York, NY 10010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3132/dvdr.2008.029DOI Listing
September 2008

Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.

Clin Endocrinol (Oxf) 2008 May 2;68(5):738-46. Epub 2007 Nov 2.

Department of Medicine, University College and Royal Free School of Medicine, University College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2265.2007.03113.xDOI Listing
May 2008

PROactive: time for a critical appraisal.

Eur Heart J 2008 Apr 28;29(8):969-83. Epub 2008 Mar 28.

Department of Medicine, Royal Free and University College Medical School, University College Hospital, Third Floor, 250 Euston Road, London NW1 2PQ, UK.

View Article

Download full-text PDF

Source
http://eurheartj.oxfordjournals.org/content/ehj/29/8/969.ful
Web Search
http://eurheartj.oxfordjournals.org/cgi/doi/10.1093/eurheart
Publisher Site
http://dx.doi.org/10.1093/eurheartj/ehn114DOI Listing
April 2008

Native and oxidized low-density lipoproteins modulate the vasoactive actions of soluble beta-amyloid peptides in rat aorta.

Clin Sci (Lond) 2007 Dec;113(11):427-34

The Hatter Cardiovascular Institute, University College London Hospital and Medical School, 67 Chenies Mews, London WC1E 6HX, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1042/CS20070082DOI Listing
December 2007

Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study.

J Am Coll Cardiol 2007 Nov 5;50(21):2051-8. Epub 2007 Nov 5.

Medical Research Council Clinical Sciences Centre, Imperial College, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2007.07.070DOI Listing
November 2007

Effects of pioglitazone on lipid and lipoprotein metabolism.

Diabetes Obes Metab 2007 Sep;9(5):640-7

Department of Medicine, Royal Free and University College Medical School, University College Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1463-1326.2007.00715.xDOI Listing
September 2007

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

January 2007

Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).

Diabetes Care 2006 Nov;29(11):2378-84

Division of Public Health and Primary Health Care, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.

View Article

Download full-text PDF

Source
http://care.diabetesjournals.org/cgi/doi/10.2337/dc06-0872
Publisher Site
http://dx.doi.org/10.2337/dc06-0872DOI Listing
November 2006

Advanced glycation endproducts in nondiabetic patients with obstructive sleep apnea.

Sleep 2006 Mar;29(3):329-33

Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong.

View Article

Download full-text PDF

Source
http://www.journalsleep.org/Articles/290308.pdf
Web Search
http://dx.doi.org/10.1093/sleep/29.3.329DOI Listing
March 2006

The use of pholasin as a probe for the determination of plasma total antioxidant capacity.

Clin Biochem 2006 Jan 2;39(1):55-61. Epub 2005 Dec 2.

Department of Medicine, Royal Free and University College London School of Medicine, London, The Middlesex Hospital, Mortimer Street, W1N 8AA London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2005.09.011DOI Listing
January 2006

Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.

Authors:
John Betteridge

Am J Med 2005 Dec;118 Suppl 12A:10-5

Department of Medicine, Royal Free and University College Medical School, Middlesex Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2005.09.013DOI Listing
December 2005

Total risk factor management in patients with type 2 diabetes.

Authors:
John Betteridge

Br J Hosp Med (Lond) 2005 Sep;66(9):529-33

University College, London WC1E 6BT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2005.66.9.19706DOI Listing
September 2005

Race-specific differences in antioxidant enzyme activity in patients with type 2 diabetes: a potential association with the risk of developing nephropathy.

Diabetes Care 2005 Jul;28(7):1698-703

Department of Cellular and Molecular Medicine, St. George's Hospital NHS Trust, Thomas Addison Diabetes Centre, London SW17 ORE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.28.7.1698DOI Listing
July 2005

Long-term risk reduction: who needs treatment?

Diabetes Res Clin Pract 2005 Jun;68 Suppl 2:S15-22

Endocrinology and Metabolism, Department of Medicine, University College London Medical School, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2005.03.016DOI Listing
June 2005

Targeting dyslipidemia--the key to CHD risk reduction in the diabetic population?

Diabetes Res Clin Pract 2005 Jun 13;68 Suppl 2:S1-2. Epub 2005 Apr 13.

Endocrinology and Metabolism, Department of Medicine, University College London Medical School, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.diabres.2005.03.014DOI Listing
June 2005

Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?

Eur J Cardiovasc Prev Rehabil 2004 Dec;11(6):521-8

Department of Diabetes & Endocrinology, UCL Hospitals, Mortimer Street, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.hjr.0000136418.47640.bcDOI Listing
December 2004

Exaggerated polymerisation of beta-amyloid 40 stimulated by plasma lipoproteins results in fibrillar Abeta preparations that are ineffective in promoting ADP-induced platelet aggregation.

Biochim Biophys Acta 2004 Nov;1674(3):305-11

Department of Medicine, Sir Jules Thorn Institute, Royal Free and University College Medical School, The Middlesex Hospital, Mortimer Street, London W1N 8AA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagen.2004.07.005DOI Listing
November 2004

Statins and diabetes.

Semin Vasc Med 2004 Nov;4(4):321-32

Endocrine Service, Hospital Clínico Universitario, University of Valencia, Avda Blasco Ibañez 15, 46010 Valencia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2004-869589DOI Listing
November 2004

Plasma beta-amyloid (A beta) 40 concentration, lipid status and age in humans.

Neurosci Lett 2004 Aug;367(1):48-50

Department of Medicine, Royal Free and University College Medical School, Sir Jules Thorn Institute, The Middlesex Hospital, Mortimer Street, London WIN 8AA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2004.05.081DOI Listing
August 2004

Soluble beta-amyloid (A beta) 40 causes attenuation or potentiation of noradrenaline-induced vasoconstriction in rats depending upon the concentration employed.

Neurosci Lett 2004 Aug;367(1):129-32

Department of Medicine, Royal Free and University College Medical School, Sir Jules Thorn Institute, The Middlesex Hospital, Mortimer Street, London W1N 8AA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2004.05.094DOI Listing
August 2004

Association between acute-phase reactants and advanced glycation end products in type 2 diabetes.

Diabetes Care 2004 Jan;27(1):223-8

Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diacare.27.1.223DOI Listing
January 2004

Potentiation of beta-amyloid polymerisation by low-density lipoprotein enhances the peptide's vasoactivity.

Biochim Biophys Acta 2004 Jan;1670(2):147-55

Department of Medicine, Royal Free and University College Medical School, Sir Jules Thorn Institute, The Middlesex Hospital, Mortimer Street, London W1N 8AA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbagen.2003.11.005DOI Listing
January 2004

Oxidised lipoproteins may promote inflammation through the selective delay of engulfment but not binding of apoptotic cells by macrophages.

Atherosclerosis 2003 Nov;171(1):21-9

Department of Biological Sciences, Molecular Medicine Research Centre, University of Warwick, Coventry CV4 7AL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.atherosclerosis.2003.07.001DOI Listing
November 2003

Human cytomegalovirus seropositivity is associated with impaired vascular function.

Circulation 2003 Aug 4;108(6):678-83. Epub 2003 Aug 4.

Department of Epidemiology and Public Health, University College London, 5 University St, London, WC1E 6JJ, UK.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/01.CIR.0000084505.54
Publisher Site
http://dx.doi.org/10.1161/01.CIR.0000084505.54603.C7DOI Listing
August 2003

CHD and diabetes--target dyslipidaemia, reduce the risk.

Diabetes Res Clin Pract 2003 Jul;61 Suppl 1:S1-2

Department of Medicine, London Medical School, University College, Mortimer Street, London W1T 3AA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0168-8227(03)00124-4DOI Listing
July 2003

Evaluation of methods for the extraction of nitrite and nitrate in biological fluids employing high-performance anion-exchange liquid chromatography for their determination.

J Chromatogr B Analyt Technol Biomed Life Sci 2002 Nov;779(2):201-9

Department of Medicine, Royal Free and University College Medical School, Gower Street Campus, The Middlesex Hospital, Mortimer Street, London W1N 8AA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1570-0232(02)00376-8DOI Listing
November 2002

Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance.

Diabetes 2002 Oct;51(10):3020-4

Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/diabetes.51.10.3020DOI Listing
October 2002

Plant sterols...from research to practice.

Atheroscler Suppl 2002 Oct;3(3):1-3

Department of Medicine, University College Medical School, The Middlesex Hospital, Mortimer Street, W1T 3AA, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1567-5688(02)00019-3DOI Listing
October 2002

A new drug target for treatment of dyslipidaemia associated with type 2 diabetes and the metabolic syndrome?

Lancet 2002 Jun;359(9325):2215-6

MRC Clinical Sciences Centre, Hammersmith Hospital, London, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(02)09315-7DOI Listing
June 2002

Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.

Am J Physiol Endocrinol Metab 2002 May;282(5):E1163-71

Medical Research Council Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London W12 ONN, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpendo.00386.2001DOI Listing
May 2002

An investigation into the mechanisms mediating plasma lipoprotein-potentiated beta-amyloid fibrillogenesis.

FEBS Lett 2002 May;518(1-3):72-8

Department of Medicine, Royal Free and University College Medical School, Sir Jules Thorn Institute, The Middlesex Hospital, Mortimer Street, W1N 8AA, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(02)02646-7DOI Listing
May 2002